• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

HPAI H5N1 elicit an attenuated type I interferon response

Sally Furniss

Well-known member
Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type I interferon response in polarized human bronchial epithelial cells

Hui Zeng, Cynthia Goldsmith, Pranee Thawatsupha, Malinee Chittaganpitch, Sunthareeya Waicharoen, Sherif Zaki, Terrence M Tumpey, and Jacqueline M. Katz*

Immunology and Pathogenesis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, and Infectious Disease Pathology Branch, Division of Viral and Rickettsial Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, Thai National Influenza Center, National Institute of Health, Ministry of Public Health, Bangkok, Thailand 11000

* To whom correspondence should be addressed. Email: jmk9@cdc.gov.

Abstract


The unparallelled spread of highly pathogenic avian influenza A (HPAI) H5N1 viruses has resulted in devastating outbreaks in domestic poultry and sporadic human infections with a high fatality rate. To better understand the mechanism(s) of H5N1 virus pathogenesis and host responses in humans, we utlized a polarized human bronchial epithelial cell model that expresses both avian alpha-2,3 and human alpha-2,6 linked sialic acid receptors on the apical surface and supports productive replication of both H5N1 and H3N2 viruses. Using this model, we compared the ability of selected 2004 HPAI H5N1 viruses isolated from humans and a recent human H3N2 virus to trigger the type I interferon response. H5N1 viruses elicited significantly less IRF3 nuclear translocation, as well as delayed and reduced production of IFN{beta} compared with the H3N2 virus. Furthermore, phosphorylation of Stat2 and induction of interferon-stimulated genes (ISGs), such as MX1, ISG15, IRF7 and RIG-I, were substantially delayed and reduced in cells infected with H5N1 virus. We also observed that the highly virulent H5N1 virus replicated more efficiently and induced a weaker interferon response than the H5N1 virus that exhibited low virulence in mammals in an earlier study. Our data suggest that the H5N1 viruses tested, especially the virus with the high pathogenicity phenotype, possess greater capability to attenuate type I IFN response compared with the human H3N2 virus. The attenuation of this critical host innate immune defense may, in part, contribute to the virulence of H5N1 viruses observed in humans.
 
Back
Top